TARGETING EZH2 FOR NOVEL COMBINATION THERAPEUTIC STRATEGIES IN AGGRESSIVE VARIANT PROSTATE CANCER - NEW AWARD...CORRECTS THE 8/6/2019 ENTRY AS A FORMULA GRANT
$255,465FY2019Department of the ArmyDOD
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc.